Remicade (infliximab) Drug Market Report

Global and Region Remicade (infliximab) Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：172
  • REPORT CODE：GMM891480
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Remicade (infliximab) Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Remicade (infliximab) Drugmarket, defines the market attractiveness level of Remicade (infliximab) Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Remicade (infliximab) Drug industry, describes the types of Remicade (infliximab) Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Remicade (infliximab) Drug market and the development prospects and opportunities of Remicade (infliximab) Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Remicade (infliximab) Drug market in Chapter 13.

    By Player:

    • Hospira

    • Celltrion Healthcare

    • Epirus Biopharmaceuticals

    • Janssen

    • Samsung Bioepsis

    By Type:

    • Brands Drugs

    • Generic Drugs

    By End-User:

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Remicade (infliximab) Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Remicade (infliximab) Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Remicade (infliximab) Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Remicade (infliximab) Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Remicade (infliximab) Drug Market Analysis and Outlook to 2022

    • 7.1 Global Remicade (infliximab) Drug Consumption (2017-2022)

    • 7.2 United States Remicade (infliximab) Drug Consumption (2017-2022)

    • 7.3 Europe Remicade (infliximab) Drug Consumption (2017-2022)

    • 7.4 China Remicade (infliximab) Drug Consumption (2017-2022)

    • 7.5 Japan Remicade (infliximab) Drug Consumption (2017-2022)

    • 7.6 India Remicade (infliximab) Drug Consumption (2017-2022)

    • 7.7 South Korea Remicade (infliximab) Drug Consumption (2017-2022)

    8 Region and Country-wise Remicade (infliximab) Drug Market Analysis and Outlook to 2028

    • 8.1 Global Remicade (infliximab) Drug Consumption Forecast (2022-2028)

    • 8.2 United States Remicade (infliximab) Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Remicade (infliximab) Drug Consumption Forecast (2022-2028)

    • 8.4 China Remicade (infliximab) Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Remicade (infliximab) Drug Consumption Forecast (2022-2028)

    • 8.6 India Remicade (infliximab) Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Remicade (infliximab) Drug Consumption Forecast (2022-2028)

    9 Global Remicade (infliximab) Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Remicade (infliximab) Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Brands Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Remicade (infliximab) Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Generic Drugs Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Generic Drugs Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Generic Drugs Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Generic Drugs Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Generic Drugs Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Generic Drugs Consumption and Growth Rate (2017-2022)

    10 Global Remicade (infliximab) Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Remicade (infliximab) Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Brands Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Remicade (infliximab) Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    11 Global Remicade (infliximab) Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Remicade (infliximab) Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Remicade (infliximab) Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Remicade (infliximab) Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Remicade (infliximab) Drug Market Competitive Analysis

    • 14.1 Hospira

      • 14.1.1 Hospira Company Details

      • 14.1.2 Hospira Remicade (infliximab) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Hospira Remicade (infliximab) Drug Product and Service

    • 14.2 Celltrion Healthcare

      • 14.2.1 Celltrion Healthcare Company Details

      • 14.2.2 Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Celltrion Healthcare Remicade (infliximab) Drug Product and Service

    • 14.3 Epirus Biopharmaceuticals

      • 14.3.1 Epirus Biopharmaceuticals Company Details

      • 14.3.2 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Product and Service

    • 14.4 Janssen

      • 14.4.1 Janssen Company Details

      • 14.4.2 Janssen Remicade (infliximab) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Janssen Remicade (infliximab) Drug Product and Service

    • 14.5 Samsung Bioepsis

      • 14.5.1 Samsung Bioepsis Company Details

      • 14.5.2 Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Samsung Bioepsis Remicade (infliximab) Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Remicade (infliximab) Drug

    • Figure Remicade (infliximab) Drug Picture

    • Table Global Remicade (infliximab) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Remicade (infliximab) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Remicade (infliximab) Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Remicade (infliximab) Drug Consumption by Country (2017-2022)

    • Figure United States Remicade (infliximab) Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Remicade (infliximab) Drug Consumption and Growth Rate (2017-2022)

    • Figure China Remicade (infliximab) Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Remicade (infliximab) Drug Consumption and Growth Rate (2017-2022)

    • Figure India Remicade (infliximab) Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Remicade (infliximab) Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Remicade (infliximab) Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Remicade (infliximab) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Remicade (infliximab) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Remicade (infliximab) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Remicade (infliximab) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Remicade (infliximab) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Remicade (infliximab) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Brands Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Brands Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Remicade (infliximab) Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Remicade (infliximab) Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Hospira (Foundation Year, Company Profile and etc.)

    • Table Hospira Remicade (infliximab) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hospira Remicade (infliximab) Drug Product and Service

    • Table Celltrion Healthcare (Foundation Year, Company Profile and etc.)

    • Table Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Healthcare Remicade (infliximab) Drug Product and Service

    • Table Epirus Biopharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Product and Service

    • Table Janssen (Foundation Year, Company Profile and etc.)

    • Table Janssen Remicade (infliximab) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Remicade (infliximab) Drug Product and Service

    • Table Samsung Bioepsis (Foundation Year, Company Profile and etc.)

    • Table Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Samsung Bioepsis Remicade (infliximab) Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US